Primary immunodeficiency

Jun 02, 2020

CSL Behring and Seattle Children's Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases

Jan 30, 2020

Kedrion Biopharma Announces Completion of Enrollment for CARES10, a Phase 3, Multi-Center Study to Assess a 10 Percent Intravenous Immunoglobulin in Adults with Primary Immunodeficiency Disease

Jul 04, 2019

Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Oct 26, 2018

GigaGen to Present Data on Recombinant Hyperimmune Gammaglobulin at the 18th Biennial Meeting of the European Society for Immunodeficiencies

Sep 19, 2018

Primary Immunodeficiency Diseases Epiomic Epidemiology Markets, 2018-2028 - Focus on 23 Key Countries

Jun 05, 2018

New SPIRIT® Software Will Save $42 Billion in Healthcare Costs with Early Detection of Primary Immunodeficiency

May 16, 2018

Understanding the immune system offers remarkable opportunities for conquering diseases

May 02, 2018

Jeffrey Modell Centers Network Sustains Vast Global Expansion

Apr 17, 2018

Jeffrey Modell Foundation Celebrates Awareness Week by Highlighting Wishes & Dreams

Feb 28, 2018

Enzyvant Launches Re:GenerationHope Initiative in Honor of Rare Disease Day 2018

Oct 13, 2017

Rep. Matsui Recognizes International Plasma Awareness Week

Sep 14, 2017

CSL Behring Joins Together With Conference Attendees to Make Donation to IPOPI